Moderna said Thursday its Covid-19 vaccine is 96 percent effective among youths aged 12 to 17, according to the results of its first clinical trials.
Moderna said Thursday its Covid-19 vaccine is 96 percent effective among youths aged 12 to 17, according to the results of its first clinical trials.